Bg pattern

ACICLOVIR SALA 250 mg POWDER FOR SOLUTION FOR INFUSION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use ACICLOVIR SALA 250 mg POWDER FOR SOLUTION FOR INFUSION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Patient Information Leaflet

Aciclovir Sala 250 mg powder for solution for infusion EFG

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor, pharmacist, or nurse.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

In this leaflet:

  1. What is Aciclovir Sala and what is it used for
  2. What you need to know before you use Aciclovir Sala
  3. How to use Aciclovir Sala
  4. Possible side effects
  5. Storage of Aciclovir Sala
  6. Contents of the pack and other information

1. What is Aciclovir Sala and what is it used for

Aciclovir Sala is a medicine that contains the active substance called aciclovir. Aciclovir belongs to a group of medicines called antivirals, which are active against herpes viruses. It works by eliminating or stopping the growth of viruses.

This medicine is indicated for:

  • Treatment of herpes simplex virus infections.
  • Prevention of herpes simplex virus infections in patients whose immune system is not working well, which means their bodies are less able to fight off infections.
  • Initial and recurrent treatment of varicella-zoster virus infections in patients whose immune system is not working well.
  • Treatment of immunocompetent patients with zoster, especially in progressive or disseminated cutaneous infections.
  • Treatment of herpetic encephalitis (inflammation of the brain, which can rarely be caused by the virus responsible for labial and genital herpes).
  • Treatment of herpes simplex virus infections in newborns and children up to 3 months.
Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you use Aciclovir Sala

Do not use Aciclovir Sala:

  • If you are allergic to aciclovir, valaciclovir, ganciclovir, or any of the excipients (listed in section 6).

Warnings and precautions

Be especially careful with Aciclovir Sala:

Consult your doctor or nurse before starting to use aciclovir:

  • If you have any kidney disease or are over 65 years old, your doctor may use a lower dose. Also, you should drink enough liquid during treatment to maintain adequate hydration.
  • If you have had a kidney transplant, your doctor should monitor your kidney function, as a slight increase in creatinine or serum urea may occur, which could be confused with a rejection reaction.
  • If you have a weakened immune system.

If you are not sure about the above circumstances, consult your doctor or nurse before using aciclovir.

Other medicines and Aciclovir Sala

Tell your doctor, pharmacist, or nurse if you are taking, or have recently taken, any other medicines, including those obtained without a prescription.

It is especially important that you talk to your doctor or pharmacist if you are taking any of the following medicines:

  • probenecid, used to treat gout;
  • cimetidine, used to treat stomach ulcers;
  • tacrolimus, cyclosporin, or mycophenolate mofetil, used to prevent the body from rejecting transplanted organs;
  • lithium, used to treat manic-depressive disorders;
  • theophylline, used to treat some respiratory disorders.

Pregnancy and Breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before using this medicine.

The safety of this medicine in pregnant women has not been established, and it will only be used in cases where the benefit-risk assessment by your doctor advises its use.

Aciclovir is excreted in breast milk, and breastfeeding is not recommended during treatment.

Driving and using machines

No data are available to limit this activity.

Important information about some of the ingredients of Aciclovir:

This medicine contains 26 mg of sodium per vial (main component of table/cooking salt). This is equivalent to 1.3% of the maximum recommended daily intake of sodium for an adult.

3. How to use Aciclovir Sala

You should never administer the medicine yourself. The medicine will always be administered by a trained person. Aciclovir will be given to you as a continuous infusion into a vein. This is where the medicine is administered slowly over 1 hour.

Aciclovir is usually administered every 8 hours.

You may receive fluids to ensure you do not become dehydrated.

The dose, frequency, and duration of the dose will depend on:

  • the type of infection you have,
  • your weight,
  • your age.

Your doctor may adjust the dose of aciclovir if:

  • you have kidney problems. If you have kidney problems, it is important that you receive plenty of fluids while being treated with aciclovir.
  • you are overweight.
  • you are over 65 years old.

Talk to your doctor before undergoing aciclovir if any of the above conditions apply to you.

Use in children

The dose of aciclovir given to:

  • children between 3 months and 12 years of age is calculated based on body surface area.
  • newborns and children up to 3 months of age is calculated based on body weight.

If a child has kidney problems, the dose of the medicine may be reduced.

Use in elderly

The dose should be reduced in patients with renal impairment.

Your doctor will indicate the dose and duration of your treatment with intravenous aciclovir. In acute herpes simplex virus infections, 5 days of treatment is usually sufficient, but the duration of treatment will depend on the severity of the infection, the patient's condition, and response to treatment. The treatment of herpetic encephalitis and neonatal herpes simplex usually lasts 10 days. The duration of prophylactic administration of intravenous aciclovir will be determined by the duration of the risk period.

If you use more Aciclovir Sala than you should:If you think you have received too much aciclovir, talk to your doctor or nurse immediately.

If you have received too much aciclovir, you may: feel confused or agitated, have hallucinations (see or hear things that do not exist), have convulsions, lose consciousness (coma).

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.

If you forget to use Aciclovir Sala

Do not administer a double dose to make up for forgotten doses.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

This medicine can cause the following side effects:

Allergic reactions(affect less than 1 in 10,000 people)

If you have an allergic reaction, stop taking aciclovir and talk to your doctor immediately. The signs may include:

  • skin rash, itching, or hives;
  • swelling of the face, lips, tongue, or other parts of your body;
  • shortness of breath, wheezing, or difficulty breathing;
  • fever of unknown origin (high temperature) and feeling of fainting, especially when standing up.

Other side effects include:

Common(affect less than 1 in 10 people)

  • nausea and vomiting;
  • skin rash with itching and appearance of hives;
  • skin reaction after exposure to light (photosensitivity);
  • itching;
  • swelling, redness, and sensitivity at the injection site.
  • Increased liver enzymes

Uncommon(affect less than 1 in 100 people)

  • Decrease in red blood cell count (anemia)
  • Decrease in white blood cell count (leukopenia)
  • Decrease in platelet count (thrombocytopenia, which can lead to more frequent nosebleeds and bruising)

Rare(affect less than 1 in 1,000 people)

  • headache or feeling of dizziness;
  • diarrhea or stomach pain;
  • fatigue;
  • fever;
  • effects on some blood and urine tests;
  • feeling of weakness;
  • feeling of agitation or confusion;
  • spasms or tremors;
  • hallucinations (seeing or hearing things that do not exist);
  • convulsions;
  • unusual feeling of sleepiness or drowsiness;
  • difficulty walking and lack of coordination;
  • difficulty speaking;
  • inability to think or judge clearly;
  • loss of consciousness (coma);
  • paralysis of part or all of your body;
  • behavioral, speech, and eye movement changes;
  • stiffness of the neck and sensitivity to light;
  • inflammation of the liver (hepatitis);
  • yellowing of the skin and the white part of the eyes (jaundice);
  • kidney problems (little or no urine output);
  • lower back pain, the area of the kidneys in your back, or just above the hips (kidney pain).

Reporting of side effects

If you experience any side effects, talk to your doctor or nurse, even if it is possible side effects not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Aciclovir Sala

Keep Aciclovir Sala out of the sight and reach of children.

This medicine does not require special storage conditions.

Do not use this medicine after the expiry date stated on the label and carton after EXP. The expiry date is the last day of the month indicated.

The solutions obtained after reconstituting the vial with 10 ml of water for injection maintain their stability for 12 hours at 25°C or for 24 hours at 2°C-8°C.

From a microbiological point of view, the solution should be used immediately after preparation. If not used immediately, the time and conditions of storage before use are the responsibility of the user.

Do not use this medicine if you observe any visible turbidity or crystallization in the solution.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Contents of the pack and other information

Composition of Aciclovir Sala

  • The active substance is aciclovir
  • Each vial contains 250 mg of aciclovir as sodium salt.
  • The other excipients are: sodium hydroxide.

Appearance of the product and pack contents

Aciclovir Sala is presented in glass vials containing a white or almost white sponge-like tablet, closed with a rubber stopper and sealed with a closure cap.

The 250 mg dose is available in 10 ml vials, in packs of 5 and 50 vials.

Not all pack sizes may be marketed.

Marketing authorization holder and manufacturer:

Laboratorio Reig Jofré, S.A.

Gran Capitán, 10 - 08970 Sant Joan Despí - Barcelona - Spain

Date of last revision of this leaflet: February 2023

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

This information is intended only for healthcare professionals

The solution should be administered only by intravenous route and in a continuous but very slow manner, so that it is administered over a period of not less than one hour.

Reconstitution and/or dilution is recommended immediately before use. The vial does not contain any preservative, so the unused solution should be discarded. If visible turbidity or crystallization appears before or during infusion, the solution should be rejected. The diluted solution should not be stored in the refrigerator.

Reconstitution of the lyophilized product:

The vial of intravenous aciclovir, which contains 250 mg of lyophilized aciclovir, should be reconstituted by adding 10 ml of water for injection or sodium chloride (0.9%) solution for intravenous infusion. The concentration of the reconstituted solution is 25 mg/ml.

Method of administration

Intravenous direct:

The reconstituted solution is administered using a controlled-rate infusion pump over a period of not less than one hour.

Intravenous infusion:

The reconstituted solution can be diluted for administration by infusion. The dilution is made totally or partially, depending on the required dose, by adding and mixing it with at least 100 ml of infusion solution, to obtain a solution with a maximum concentration of 0.5% (250 mg/50 ml). The contents of 2 vials (500 mg of aciclovir) can be added to 100 ml of infusion solution, and if the required dose is higher than 500 mg, a second volume of infusion solution can be used.

Aciclovir intravenous is compatible with the following infusion solutions:

  • Sodium chloride (0.45%, 0.9% p/v).
  • Sodium chloride (0.18% p/v) and glucose (4% p/v).
  • Sodium chloride (0.45% p/v) and glucose (2.5% p/v)
  • Sodium lactate (Hartmann solution)

Aciclovir intravenous, once added to the infusion solution, should be shaken vigorously to ensure perfect mixing.

After accidental infusion of intravenous aciclovir, severe inflammation of the extravascular tissue may occur, sometimes followed by ulcers. Infusion using mechanical pumps poses greater risks than gravity infusion. Phlebitis and inflammation at the infusion site may occur.

Expiry date

Do not use Aciclovir Sala 250 mg powder for solution for infusion after the expiry date stated on the packaging.

Date of last revision of this leaflet: February 2023

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for ACICLOVIR SALA 250 mg POWDER FOR SOLUTION FOR INFUSION

Discuss questions about ACICLOVIR SALA 250 mg POWDER FOR SOLUTION FOR INFUSION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for ACICLOVIR SALA 250 mg POWDER FOR SOLUTION FOR INFUSION?
ACICLOVIR SALA 250 mg POWDER FOR SOLUTION FOR INFUSION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in ACICLOVIR SALA 250 mg POWDER FOR SOLUTION FOR INFUSION?
The active ingredient in ACICLOVIR SALA 250 mg POWDER FOR SOLUTION FOR INFUSION is aciclovir. This information helps identify medicines with the same composition but different brand names.
Who manufactures ACICLOVIR SALA 250 mg POWDER FOR SOLUTION FOR INFUSION?
ACICLOVIR SALA 250 mg POWDER FOR SOLUTION FOR INFUSION is manufactured by Laboratorio Reig Jofre, S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of ACICLOVIR SALA 250 mg POWDER FOR SOLUTION FOR INFUSION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether ACICLOVIR SALA 250 mg POWDER FOR SOLUTION FOR INFUSION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to ACICLOVIR SALA 250 mg POWDER FOR SOLUTION FOR INFUSION?
Other medicines with the same active substance (aciclovir) include ACICLOVIR ACCORD 25 mg/ml CONCENTRATE FOR INFUSION SOLUTION, ACICLOVIR ACCORD 250 mg POWDER FOR INJECTABLE SOLUTION AND FOR INFUSION, ACICLOVIR ALTAN 250 mg POWDER FOR SOLUTION FOR INFUSION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media